Surgery Partners Cash on Hand 2013-2026 | SGRY

Surgery Partners cash on hand from 2013 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Surgery Partners Annual Cash on Hand
(Millions of US $)
2025 $240
2024 $270
2023 $196
2022 $283
2021 $390
2020 $318
2019 $93
2018 $184
2017 $175
2016 $70
2015 $58
2014 $75
2013 $13
Surgery Partners Quarterly Cash on Hand
(Millions of US $)
2026-06-30 $217
2026-03-31 $182
2025-12-31 $240
2025-09-30 $203
2025-06-30 $250
2025-03-31 $229
2024-12-31 $270
2024-09-30 $222
2024-06-30 $214
2024-03-31 $185
2023-12-31 $196
2023-09-30 $236
2023-06-30 $177
2023-03-31 $246
2022-12-31 $283
2022-09-30 $155
2022-06-30 $227
2022-03-31 $379
2021-12-31 $390
2021-09-30 $330
2021-06-30 $465
2021-03-31 $542
2020-12-31 $318
2020-09-30 $450
2020-06-30 $326
2020-03-31 $195
2019-12-31 $93
2019-09-30 $111
2019-06-30 $117
2019-03-31 $143
2018-12-31 $184
2018-09-30 $79
2018-06-30 $96
2018-03-31 $113
2017-12-31 $175
2017-09-30 $200
2017-06-30 $57
2017-03-31 $56
2016-12-31 $70
2016-09-30 $55
2016-06-30 $52
2016-03-31 $135
2015-12-31 $58
2015-09-30 $57
2013-12-31 $13
Sector Industry Market Cap Revenue
Medical Medical Services $1.787B $3.309B
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.177B 25.78
CVS Health (CVS) United States $120.850B 12.05
HCA Healthcare (HCA) United States $91.758B 14.27
Elevance Health (ELV) United States $90.552B 14.21
Cencora (COR) United States $61.693B 18.85
Natera (NTRA) United States $50.563B 0.00
Labcorp Holdings (LH) United States $26.274B 18.52
Viatris (VTRS) United States $19.124B 6.61
Medpace Holdings (MEDP) United States $17.319B 36.37
EUROFINS SCIENT (ERFSF) Luxembourg $16.369B 0.00
DiDi Global (DIDIY) China $16.046B 176.00
Revvity (RVTY) United States $15.643B 26.20
Solventum (SOLV) United States $15.330B 12.69
ICON (ICLR) Ireland $13.204B 17.94
Charles River Laboratories (CRL) United States $13.027B 27.56
BrightSpring Health Services (BTSG) United States $11.642B 40.03
Avantor (AVTR) United States $10.443B 18.83
BioMerieux (BMXMF) France $10.192B 0.00
Caris Life Sciences,�Inc (CAI) United States $8.054B 79.17
HealthEquity (HQY) United States $7.983B 26.01
Sonic Healthcare (SKHHY) Australia $6.771B 0.00
PACS (PACS) United States $6.662B 22.39
GETINGE (GNGBY) Sweden $6.654B 18.79
CochLear (CHEOY) Australia $6.327B 0.00
MiniMed (MMED) United States $6.193B 0.00
Bausch + Lomb (BLCO) Canada $6.157B 23.28
Sotera Health (SHC) United States $5.416B 22.33
Concentras Parent (CON) United States $4.542B 22.40
Organon (OGN) United States $3.587B 4.55
GeneDx Holdings (WGS) United States $2.822B 262.89
CareDx (CDNA) United States $2.723B 309.65
Amplifon S.p.A (AMFPF) Italy $2.466B 12.74
Pediatrix Medical (MD) United States $2.169B 12.71
Alignment Healthcare (ALHC) United States $2.151B 54.58
Establishment Labs Holdings (ESTA) United States $2.130B 0.00
Progyny (PGNY) United States $2.130B 30.17
COMPASS Pathways (CMPS) United Kingdom $1.912B 0.00
Sonida Senior Living (SNDA) United States $1.907B 0.00
Bora Pharmaceuticals, - (BORAY) Taiwan $1.695B 10.18
Freenome (FRNM) United States $1.573B 0.00
Agilon Health (AGL) United States $1.547B 0.00
Ardent Health (ARDT) United States $1.508B 8.62
InnovAge Holding (INNV) United States $1.490B 0.00
Nutex Health (NUTX) United States $1.475B 8.45
Ryman Healthcare (RYHTY) New Zealand $1.241B 0.00
Omada Health (OMDA) United States $1.204B 245.88
GoodRx Holdings (GDRX) United States $1.196B 23.27
Teladoc Health (TDOC) United States $1.195B 0.00
CryoPort (CYRX) United States $0.826B 0.00
Enhabit (EHAB) United States $0.709B 25.89
GMR Solutions (GMRS) United States $0.688B 0.00
Oncology Institute (TOI) United States $0.507B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.504B 0.00
SBC Medicals (SBC) United States $0.472B 9.77
Strata Critical Medical (SRTA) United States $0.468B 0.00
Forward Industries (FWDI) United States $0.449B 0.00
Auna S.A (AUNA) Luxembourg $0.382B 5.55
Shoulder Innovations (SI) United States $0.374B 0.00
Biodesix (BDSX) United States $0.292B 0.00
Embecta (EMBC) United States $0.288B 2.50
So-Young (SY) China $0.276B 0.00
LifeMD (LFMD) United States $0.164B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
Park Dental Partners (PARK) United States $0.098B 0.00
SkinHealth Systems (SKIN) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.079B 0.00
QDM (QDMI) Hong Kong, SAR China $0.068B 8.06
Tevogen (TVGN) United States $0.050B 0.00
DocGo (DCGO) United States $0.038B 0.00
Lifeward (LFWD) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.013B 0.00
Ainos (AIMD) United States $0.010B 0.00
Basel Medical Group (BMGL) Singapore $0.008B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
XWELL (XWEL) United States $0.008B 0.00
Aclarion (ACON) United States $0.008B 0.00
IceCure Medical (ICCM) Israel $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
20/20 Biolabs (AIDX) United States $0.006B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
Pomdoctor - (POM) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Synergy CHC (SNYR) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00